{
    "title": "COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9002859/COVID-R-D-Alliance-launches-trial-Amgen-UCB-Takeda-drugs.html",
    "date": "2020-11-30",
    "keywords": [
        "trial",
        "covid19",
        "response",
        "study",
        "beasley",
        "disease",
        "research",
        "development",
        "health",
        "care",
        "sa",
        "takeda",
        "monday",
        "severity",
        "part",
        "amp",
        "alliance",
        "group",
        "biotechnology",
        "psoriasis",
        "drug",
        "otezla",
        "antiinflammatory",
        "lanadelumab",
        "immune",
        "systeminhibitor",
        "zilucoplan",
        "bodys",
        "coronavirus",
        "tissue",
        "damage",
        "rationale",
        "effect",
        "amgen",
        "chief",
        "availability",
        "vaccine",
        "record",
        "placebo",
        "variety",
        "class",
        "inflammation",
        "arthritis",
        "survival",
        "illness",
        "covid",
        "rampd",
        "unit",
        "anticipation",
        "rise",
        "fall",
        "russia",
        "south",
        "africa",
        "country",
        "range",
        "patel",
        "officer",
        "reporting",
        "deena",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}